ID
43233
Description
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia; ODM derived from: http://clinicaltrials.gov/show/NCT02034227
Lien
http://clinicaltrials.gov/show/NCT02034227
Mots-clés
Versions (3)
- 03/08/2015 03/08/2015 - Julian Varghese
- 03/08/2015 03/08/2015 - Julian Varghese
- 20/09/2021 20/09/2021 -
Téléchargé le
20 septembre 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Myeloid Leukemia NCT02034227
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
Description
Exclusion Criteria
Description
are eligible for any standard therapy known to be life prolonging or life saving
Type de données
boolean
Description
have diagnosis of aml french-american-british (fab) classification (fab) m3 (acute promyelocytic leukemia (apl))
Type de données
boolean
Alias
- UMLS CUI [1]
- C0457329
Description
are receiving concurrent chemotherapy, radiotherapy, immunotherapy, biological or hormonal treatment for cancer.
Type de données
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C1531518
- UMLS CUI [5]
- C0279025
Description
have undergone anticancer therapy including chemotherapy (except for hydroxycarbamide at a maximum daily dose of 3000 mg), endocrine therapy, immunotherapy, or the use of other investigational agents within 4 weeks before study entry.
Type de données
boolean
Alias
- UMLS CUI [1]
- C3665472
- UMLS CUI [2]
- C0279025
- UMLS CUI [3]
- C0021083
- UMLS CUI [4]
- C0020402
Description
prior radiation therapy with volume of bone marrow treated over 25%.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0005953
- UMLS CUI [1,3]
- C0439165
Description
use of immunosuppressive therapy, including systemic steroids within 7 days before the first dose of sg2000.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0455630
- UMLS CUI [2]
- C0149783
Description
hyperleukocytosis (blast counts >30 000/mm3).
Type de données
boolean
Alias
- UMLS CUI [1]
- C3805210
Description
history of allogeneic stem cell or solid organ transplantation.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0029216
- UMLS CUI [2]
- C2242529
Description
positive serology for human immunodeficiency virus (hiv), hepatitis b or hepatitis c or have hiv-aids, or active hepatitis b or c.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019699
- UMLS CUI [2]
- C0744837
- UMLS CUI [3]
- C0850489
- UMLS CUI [4]
- C0001175
Description
history of other invasive malignancy within 3 years except for cervical carcinoma in situ, nonmelanomatous carcinoma of the skin or ductal carcinoma in situ of the breast that has been surgically cured.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0677898
- UMLS CUI [2]
- C0007099
- UMLS CUI [3,1]
- C0007114
- UMLS CUI [3,2]
- C1518408
Description
have any coexisting medical condition that will substantially increase the risk associated with the subject's participation in the study.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2348568
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0012634
Description
have psychiatric disorders or altered mental status precluding understanding of the informed consent process and/or completion of necessary studies.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1549479
- UMLS CUI [1,3]
- C0004936
Description
have persistent grade 2 or greater toxicities from any cause (except alopecia or peripheral neuropathy).
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826262
- UMLS CUI [2]
- C0002170
- UMLS CUI [3]
- C0031117
Description
are pregnant or breast-feeding.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Similar models
Eligibility Acute Myeloid Leukemia NCT02034227
- StudyEvent: Eligibility Acute Myeloid Leukemia NCT02034227
C0205269 (UMLS CUI [1,2])
C0023467 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C0001779 (UMLS CUI [3])
C0278787 (UMLS CUI [4,1])
C0332293 (UMLS CUI [4,2])
C0059985 (UMLS CUI [4,3])
C0023434 (UMLS CUI [5,1])
C0332293 (UMLS CUI [5,2])
C0002073 (UMLS CUI [5,3])
C0879626 (UMLS CUI [1,2])
C0002170 (UMLS CUI [2])
C0442874 (UMLS CUI [3])
C0332298 (UMLS CUI [1,2])
C0020402 (UMLS CUI [1,3])
C0232805 (UMLS CUI [2])
C0430064 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0279025 (UMLS CUI [5])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0020402 (UMLS CUI [4])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2])
C2242529 (UMLS CUI [2])
C0744837 (UMLS CUI [2])
C0850489 (UMLS CUI [3])
C0001175 (UMLS CUI [4])
C0007099 (UMLS CUI [2])
C0007114 (UMLS CUI [3,1])
C1518408 (UMLS CUI [3,2])
C1549479 (UMLS CUI [1,2])
C0012634 (UMLS CUI [1,3])
C1549479 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,3])
C0002170 (UMLS CUI [2])
C0031117 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
Aucun commentaire